Child Development

2
Pipeline Programs
5
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Heidelberg Pharma
Heidelberg PharmaGermany - Ladenburg
1 program
1
AzithromycinPhase 41 trial
Active Trials
NCT03187834Completed252Est. Sep 2019
Alliance Pharmaceuticals
2 programs
1
Fortified YoghurtPhase 31 trial
International Guide for Monitoring Child DevelopmentN/A1 trial
Active Trials
NCT04665297Active Not Recruiting624Est. Apr 2026
NCT00980733Unknown1,325Est. Aug 2010
One Biosciences
One BiosciencesFrance - Paris
1 program
Infant formulaN/A1 trial
Active Trials
NCT03487094CompletedEst. Jul 2020
Genesis Therapeutics
Genesis TherapeuticsCA - Burlingame
1 program
Semillas de ApegoN/A1 trial
Active Trials
NCT03502252CompletedEst. Nov 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Heidelberg PharmaAzithromycin
Alliance PharmaceuticalsFortified Yoghurt
Alliance PharmaceuticalsInternational Guide for Monitoring Child Development
One BiosciencesInfant formula
Genesis TherapeuticsSemillas de Apego

Clinical Trials (5)

Total enrollment: 2,201 patients across 5 trials

Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso

Start: Jul 2017Est. completion: Sep 2019252 patients
Phase 4Completed

Efficacy of Micronutrient Fortified Yoghurt in School Children for Health Benefits

Start: Sep 2008Est. completion: Aug 20101,325 patients
Phase 3Unknown
NCT04665297Alliance PharmaceuticalsInternational Guide for Monitoring Child Development

A Hybrid Effectiveness/Implementation Trial of the International Guide for Monitoring Child Development

Start: Jan 2023Est. completion: Apr 2026624 patients
N/AActive Not Recruiting

Growth and Tolerance of Infants Fed Formula for 16 Weeks

Start: Jul 2018Est. completion: Jul 2020
N/ACompleted

Experimental Evaluation of Semillas de Apego

Start: Mar 2018Est. completion: Nov 2020
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
5 companies competing in this space